The Toxin in Three-Quarters of African Maize

Fumonisins — mycotoxins produced by Fusarium fungi — contaminate 72.6% of maize samples in sub-Saharan Africa, nearly double the prevalence of aflatoxin, and are linked to esophageal cancer, neural tube defects, and childhood stunting. Yet fumonisins receive a fraction of the research funding, regulatory attention, and intervention effort directed at aflatoxin. This disparity has three structural causes. First, aflatoxin causes acute, lethal outbreaks that generate headlines and emergency funding responses, while fumonisin harm is chronic and population-level — harder to attribute to a specific exposure and therefore harder to fund. Second, the entire biocontrol and post-harvest toolkit developed for aflatoxin has limited relevance to fumonisins: aflatoxin is produced by Aspergillus fungi during post-harvest storage, while fumonisin contamination is driven by Fusarium fungi during pre-harvest crop growth — a fundamentally different point in the production chain requiring different interventions. Third, no field-deployable rapid test exists for fumonisins at the chronic-exposure concentrations that matter for populations where maize constitutes 40%+ of dietary calories. Existing lateral flow assays target export thresholds (1-2 ppm), missing the lower concentrations (0.1-0.5 ppm) that produce harm under sustained high-maize diets.

Maize is the dietary staple for over 300 million people in sub-Saharan Africa, often comprising 40-70% of caloric intake. At these consumption levels, even relatively low fumonisin concentrations produce cumulative chronic exposure well above established tolerable daily intake levels. Fumonisins inhibit ceramide synthase, disrupting sphingolipid metabolism in ways linked to neural tube defects (NTDs) — regions with high fumonisin exposure show NTD rates 2-5 times the global average. Esophageal cancer incidence in the "esophageal cancer belt" of eastern Africa correlates strongly with fumonisin-contaminated maize consumption. Unlike aflatoxin, where post-harvest hermetic storage and Aflasafe biocontrol offer proven interventions, fumonisin contamination is determined before harvest by factors including Fusarium infection timing, insect damage during grain fill, moisture stress, and crop variety — none of which are addressed by the post-harvest intervention infrastructure that donors have built for aflatoxin. Most African countries have set regulatory limits for aflatoxin but not for fumonisins, leaving the problem invisible to food safety enforcement.

Aflatoxin biocontrol products (Aflasafe and analogs) have no effect on Fusarium-driven fumonisin contamination — they target a different fungal genus operating at a different stage of crop production. Hermetic storage bags (PICS, GrainPro) prevent aflatoxin-producing Aspergillus from growing during storage but do not address fumonisin contamination that has already occurred in the field before harvest. Sorting and cleaning maize to remove visibly damaged kernels reduces fumonisin levels by 40-60% in trials but is labor-intensive and removes a significant fraction of the harvest — economically unacceptable for subsistence farmers. Existing rapid detection strips (lateral flow immunoassays) for fumonisins have detection limits of 1-2 ppm, appropriate for export inspection but insufficient for identifying chronic-exposure-level contamination in subsistence diets. Pre-harvest interventions — resistant crop varieties, optimized planting dates, insect management during grain fill — have been identified in research but none have been operationalized at scale in smallholder systems. Fumonisin-resistant maize varieties developed through conventional breeding exist but are not yet available in locally adapted germplasm for the major production regions.

A field-deployable rapid fumonisin test with a detection limit of 0.1-0.5 ppm — an order of magnitude more sensitive than current lateral flow assays — calibrated for the chronic exposure thresholds relevant to high-maize diets rather than the acute/export thresholds that drive current assay design. This would make the problem measurable at the point where it matters. Pre-harvest Fusarium management packages integrating resistant varieties, optimized planting windows, and biological control agents active against Fusarium (distinct from Aflasafe-type products) need to be developed and validated for the 3-4 most important maize production systems in eastern and southern Africa. Regulatory frameworks that establish fumonisin limits for domestically consumed grain — not just export product — would create institutional demand for monitoring and intervention. Dietary diversification strategies that reduce maize dependency would lower per-capita fumonisin exposure even without reducing contamination levels.

An analytical chemistry or bioengineering team could develop and validate a lateral flow assay or electrochemical biosensor for fumonisins with a target detection limit of 0.2 ppm in ground maize flour, benchmarking against HPLC-MS reference methods using naturally contaminated samples from eastern African maize. A food science team could quantify the fumonisin reduction achieved by different traditional and improved maize processing methods (nixtamalization, fermentation, sorting, dehulling) under realistic smallholder conditions, producing a ranked intervention guide for extension services. An epidemiology or public health team could estimate the population-attributable fraction of neural tube defects associated with fumonisin exposure in a high-maize-consumption region, using existing dietary survey data and fumonisin contamination databases. Relevant disciplines: analytical chemistry, biomedical engineering, food science, plant pathology, epidemiology, public health.